Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman Agreement Will Give Biosite Automated Platform For BNP Assay

This article was originally published in The Gray Sheet

Executive Summary

Biosite will leverage Beckman Coulter's U.S. installed base of automated immunoassay analyzers to grow its market share in BNP testing under a long-term development deal between the firms

You may also be interested in...



Beckman Coulter Buys Cardiac Test Developer Biosite For $1.55 Billion

In a $1.55 billion acquisition plan announced March 25, Beckman Coulter looks to combine its strength as a leading manufacturer of lab instruments with the complementary expertise of diagnostic test developer Biosite

Beckman Coulter Buys Cardiac Test Developer Biosite For $1.55 Billion

In a $1.55 billion acquisition plan announced March 25, Beckman Coulter looks to combine its strength as a leading manufacturer of lab instruments with the complementary expertise of diagnostic test developer Biosite

BioSite Launches Triage Stroke Panel In Europe, Defends BNP Test Share

BioSite's European launch of its Triage stroke panel comes as the firm faces increasing BNP test pricing pressure from Abbott Labs

Related Content

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel